The Novo Nordisk Foundation is an enterprise foundation with philanthropic objectives, established in Denmark in 1924. Our vision is to improve people’s health and contribute to the sustainability of society and the planet. Through strategic grant giving, partnerships, and long-term investments, the Foundation seeks to generate impact that benefits both current and future generations. Community guidelines We welcome dialogue on our channels and value respectful engagement. However, we reserve the right to remove comments that are offensive, racist, sexist, discriminatory, spam, or otherwise inappropriate. Repeated violations may result in being blocked from our channels.
Unlock the market timeline & signal feed
162 signals in the last 90 days.
The order this company entered each market — oldest to newest
Sign up to see the full signal feed
How Novo Nordisk Foundation's international expansion compares to its competitors
Novo Nordisk FoundationYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 Novo Nordisk FoundationYou | 4 | 0 | -72% | 162 | 11 |
Senior Digital Workplace Manager (Maternity Cover)
View postingGentofte, Capital Region of Denmark, Denmark · last wk.
Kontorelever
View postingGentofte, Capital Region of Denmark, Denmark · 3w ago
Student Assistant, Public Affairs
View postingGentofte, Capital Region of Denmark, Denmark · 3w ago
We’re launching a new roadmap to help unlock the potential of regenerative medicine in Europe. Based on a major analysis, it sets out what it will take to move from strong science to real-world therapies that treat or even cure disease.Today, Europe has the scientific foundations to lead globally. But too often, new knowledge isn’t translated into startups, clinical programmes, and approved treatments.We commissioned an analysis of Europe’s regenerative medicine landscape to better understand wh ...
Ended
Novo Nordisk Foundation and Global Health EDCTP3 launch partnership to advance global health research - Novo Nordisk Fonden
Ended
From foundational mRNA breakthroughs to unlocking the genetic mysteries of rare diseases, recipients of the Novo Nordisk Foundation Prize for Biomedicine don’t just study human health - they revolutionize it.This prestigious award honors outstanding scientists whose pioneering research has led to major medical breakthroughs and life-saving clinical applications.If you know a visionary scientist whose work is fundamentally shifting the paradigm of biomedicine, their contributions deserve the glob ...
EndedINTREPID Alliance reports only 8 viral diseases in clinical trials across 6 of 14 high-risk viral families, with 3 families having no antiviral development, highlighting critical gaps in pandemic preparedness.
Novo Nordisk Foundation launches CardioMetabolic Bridge, a pan-European initiative to accelerate drug discovery for cardiometabolic diseases by bridging academic research and therapeutic development with funding and mentorship.
Novo Nordisk Foundation, led by Lene B. Oddershede, is investing in quantum computing for healthcare and drug discovery, with a long-term perspective of about 10 years.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Novo Nordisk Foundation's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
